Richter Gedeon Nyrt
Gedeon Richter Plc. is a major multinational pharmaceutical and biotechnology enterprise headquartered in Hungary that engages in the comprehensive research, development, production, and marketing of pharmaceutical products. The company operates through core business segments focusing on proprietary prescription drugs, generic medicines, and advanced biotechnology solutions, with specialized international expertise in women's health. Its principal product offerings include original and generic central nervous system medications, cardiovascular drugs, and specialized gynecological therapeutics distributed across numerous international healthcare markets and distribution partnerships. Richter Gedeon's main revenue drivers are global commercial sales of proprietary pharmaceutical formulations and specialized therapeutic products, serving patients worldwide. As a leading pharmaceutical manufacturer in Central and Eastern Europe, the company holds a strong market position within the international healthcare sector. Headquartered in Budapest, Hungary, Richter Gedeon is publicly listed and traded with common shares on the Budapest Stock Exchange.
28 of the funds FundTelligence covers report a position in Richter Gedeon Nyrt.
- Sector
- Health Care
- Country
- Hungary
- Funds holding it
- 28
- Exposure themes
- Reproductive health, Treatment, Women's Health
Funds holding Richter Gedeon Nyrt
- Schroder ISF Emerging Europe — Schroders · 4.76 % (full portfolio disclosed, June 2026)
- Swedbank Robur Emerging Europe — Swedbank · 2.19 % (full portfolio disclosed, October 2026)
- Storebrand Like Muligheter — Storebrand · 1.85 % (full portfolio disclosed, October 2026)
- Templeton Eastern Europe Fund — Franklin Templeton · 1.85 % (full portfolio disclosed, September 2026)
- Handelsbanken EMEA Tema — Handelsbanken · 1.31 % (full portfolio disclosed, October 2026)
- DNB Fund Women's Health — DNB · 1.29 % (full portfolio disclosed, August 2026)
- Sparinvest Ethical Emerging Markets Value — Sparinvest · 1.16 % (full portfolio disclosed, September 2026)
- Templeton Emerging Markets Smaller Companies Fund — Franklin Templeton · 1.06 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 28 funds holding it.